Conclusions: This is the first study demonstrating a molecular makeup of human thyroid circadian clock. Characterization of the thyroid clock machinery alterations upon thyroid nodule malignant transformation contributes to understanding the connections between circadian clocks and oncogenic transformation. Moreover, it might help improving the thyroid nodule pre-operative diagnostics.
quent. Fine-needle aspiration (FNA) biopsy is recommended for the clinical evaluation of thyroid nonsecreting nodules Ն 1cm. FNA is currently the most accurate and safe tool in the management and classification of patients with thyroid nodules. Thyroid FNA represents a test of choice for preoperative diagnostic in PTC cases, allowing reliable recognition of this malignancy type. In cases of FTC, however, FNA does not allow clear discrimination between benign follicular lesions (nodular hyperplasia, adenomatous goiter and follicular adenoma) and a malignant follicular lesion (FTC), and thus represents only screening test. Therefore, surgery is required for all lesions diagnosed as suspicious for a follicular neoplasm, and for some of the lesions of undetermined significance (3) . Postoperatively, 70%-90% of these cases are found to be benign, revealing a significant rate of unnecessary surgery, complications, and morbidity (4) . Multiple ultrasonography, immunohistochemical or genetic features have been associated with malignancy, but none of them is by itself sufficiently accurate to distinguish follicular adenoma from carcinoma with high probability (5) . The search for preoperative markers for thyroid malignancies stays therefore of utmost clinical importance.
Circadian oscillation of biological processes has been described in virtually all light-sensitive organisms. It reflects the existence of intrinsic clocks with near 24 h oscillation periods. The mammalian clock has a hierarchical structure, in which a master pacemaker residing in the brain's suprachiasmatic nuclei must establish phase coherence in the body by synchronizing billions of individual cellular clocks every day (6) . Central and peripheral clocks have a similar molecular makeup. Moreover, this rhythm generating circuitry is functional in most cell types (7) . In addition to intrinsic circadian oscillator, another fundamental attribute of a cell is its ability to divide and multiply. While the circadian clock is the body's molecular time-keeping system, the cell division clock executes a precise temporal control mechanism with multiple checkpoints for proper cell division. Recent findings revealed that circadian and cell cycle clocks might be linked (7) (8) (9) . Furthermore, clock genes have been linked to the cell cycle, DNA damage, apoptosis control, and carcinogenesis (10, 12) . Perturbation of circadian rhythms both in humans (shift workers) and animals has been associated with malignant transformations (13) . Taken together, these data suggest a strong link between the circadian clock and the cell cycle.
Turning to the thyroid gland regulating hormones, both Thyrotropin Releasing Hormone (TRH) and Thyroid Stimulating Hormone (TSH) exhibit pronounced circadian oscillations in the blood with a peak between 2AM and 4AM in healthy subjects. Moreover, low amplitude circadian variations were reported for the thyroid hormones (total thyroxine (T3) and triiodothyronine (T4) (14) ), suggesting circadian function for the thyroid gland. We therefore aimed at characterizing the clock machinery in human healthy thyroid tissue, and in benign and malignant thyroid nodules.
Materials and Methods

Study participants and thyroid tissue sampling
Fresh thyroid tissue samples (1cm 3 ) were obtained from patients undergoing thyroidectomy for thyroid cancer or suspicious nodule, with the written informed consent. Donor characteristics are summarized in Table 1 . The subjects were not kept on constant routine prior to the surgery. The biopsy material was collected in a daytime dependent manner, with all the surgeries performed in the time-window between 8AM and 2PM. The study protocol was approved by the local Ethics Committee (CER 11-014). Malignant tumors were classified by histopathological analysis according to the World Health Organization Histological Classification of Thyroid Tumors (15) and staged according to the AJCC Cancer Staging Manual seventh ed. One part of the obtained thyroid tissue was deep-frozen and kept for tissue transcript analysis; the other part was immediately processed to establish primary culture.
Human primary thyroid cell culture
Fresh tissue biopsies were subjected to Type II collagenase (Life Technologies) digestion for one hour. Cells were grown in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% FBS and 1% penicillin/streptomycin. Primary thyrocytes were used for the experiments after reaching confluence, typically after 7 d of culture.
In vitro cells synchronization
To synchronize thyrocytes, dexamethasone was added to the culture medium at a final concentration of 100 nM. Following 30 min incubation at 37°C in a cell culture incubator, dexamethasone was washed away and replaced with normal medium, as described (16) . Cells were harvested every 6 h during 36 h, deepfrozen and kept at -80°C.
RNA extraction and quantitative RT-PCR (qPCR) analysis
Total RNA from frozen thyroid biopsies or from thyrocytes was prepared using RNA spin II kit (Macherey-Nagel). Tissue biopsies were first homogenized using a Polytron homogenizer. Half a g of RNA was reverse-transcribed using Superscript III reverse transcriptase (Invitrogen) and random hexamers, PCR amplified and quantified as previously described (17) . Mean values for each experiment were calculated from technical triplicates of PCR assays for each sample, and normalized to the mean of those obtained for GAPDH and 9S transcripts served as internal controls. Primers used for this study are listed in Supplementary Table 1 . 
Lentivectors and lentiviral production
Bmal1-luciferase (Bmal1-luc) (18) lentiviral particles were produced as previously described (17), 100-fold concentrated, and used for the transduction of thyrocytes at MOI ϭ 5.
Bioluminescence monitoring
Bioluminescence patterns were monitored from dexamethasone synchronized human thyrocytes four days following Bmal1-luc lentiviral transduction, as previously described (16, 17) . Briefly, synchronized cells were transferred to Actimetrics LumiCycle placed in a 37°C light-tight incubator and bioluminescence from each dish was continuously monitored using a Hamamatsu photomultiplier tube detector assembly. Actimetrics LumiCycle Analysis program was used to assess the rhythm parameters.
Cosinor Analysis
To quantify circadian oscillatory gene expression profiles, we have developed new software CosinorJ, based on a cycling function model representing the extension of the standard Cosinor method (19): where T is the period, AϩBt is the range of oscillations, C is the mesor and is the acrophase (see Supplementary Methods for details). It is freely available at http://bigwww.epfl.ch/algorithms.html
Statistics
The results are expressed as the means Ϯ SEM unless stated otherwise. Mann-Whitney test was applied to compare transcript expression levels between the different tissue types.
Results
Bmal1 transcript is up-regulated, while Cry2 is down-regulated in FTC and PTC nodule tissues
In an attempt to assess core-clock transcript levels in benign and malignant thyroid tissues, biopsies from human normal thyroid tissue, benign follicular nodules, FTC or PTC were obtained after thyroidectomy (see Table 1 for patient characteristics). qPCR analysis of core-clock transcripts was performed in healthy thyroid tissue (N ϭ 4 subjects), benign thyroid nodules (N ϭ 10 subjects), FTC (N ϭ 8 subjects) and PTC nodules (N ϭ 14 subjects). No difference was observed between healthy tissue and benign nodules for all of the analyzed transcript expression levels (data not shown). By contrast, Bmal1 expression was 13 fold upregulated, while Cry2 expression was about two fold down-regulated in PTC compared to benign nodules ( Table 2 ). In addition to the core-clock transcript changes, we found up-regulated levels of Timp1 and down-regulated levels of Gadd153 transcripts in PTC (Supplementary Figure 1A , left panel, and 1B). This finding is in a good agreement with previous publications (20, 21) . Of note, significant correlation was observed between Timp1 and Bmal1 transcript levels obtained in PTC (Supplementary Figure 1A , right panel), further validating our conclusion regarding Bmal1 up-regulation.
Self-sustained circadian oscillators are operative in human primary thyrocytes
Prompted by marked differences in core-clock transcript levels between benign and malignant thyroid tissues, we next aimed at characterizing the human thyroid clock molecular makeup. Given obvious obstacles for studying peripheral clocks in human beings, we employed cultured human primary thyrocytes synchronized in vitro. Cells were established from fresh normal thyroid tissue obtained after thyroidectomy (Table 1 , samples labeled with #). To confirm thyrocyte cell identity, thyroglobulin expression was assessed by indirect immunofluorescence. Thyroglobulin was detected in 75.3% of cells (1232 positive out of total 1634 cells) after 7 d in culture (Supplementary Figure 2) .
To assess the endogenous core-clock transcript expression profiles around-the-clock, confluent primary thyrocytes were synchronized by a dexamethasone pulse, since The relative mRNA expression of each transcript was normalized to average of Gapdh and 9S, and then reported to the mean value of the respective transcript levels in nodular benign tissues. Results were expressed as mean Ϯ SEM. Mann-Whitney test was applied to assess the significance in the transcript expression level differences between FTC or PTC as compared to benign nodules (*: P Ͻ .05, **: P Ͻ .01 and ***: P Ͻ .001).
dexamethasone has been previously demonstrated to synchronize efficiently circadian oscillators in various cellular systems (17, 22) . mRNA accumulation patterns from synchronized thyrocytes were monitored every 6 h during 36 h by quantitative RT-PCR, using amplicons for Bmal1, Cry1, Cry2, Per1, Per2, Per3, Reverb␣, and Dbp. The values were normalized to the average obtained for Gapdh and 9S transcripts, which accumulated to similar levels throughout the day. Endogenous Bmal1 transcript abundance exhibited high-amplitude circadian oscillations, in phase with Cry1, and antiphasic to those of Reverb␣, Per1-3 and Dbp transcripts (Figure 2 ), in good agreement with previous studies on human skin dermal fibroblasts (23) and human pancreatic islets (17) . Cry2 mRNA exhibited weak oscillatory profile, in phase with Reverb␣, as expected from previous studies (17) . For the quantification of these datasets, we used CosinorJ software, representing the optimization of the existing Cosinor method (19) Figure 3) . Taken together, our experiments reveal the presence of cell-autonomous self-sustained circadian oscillators in in vitro synchronized human primary thyrocytes, with the characteristics comparable to other human peripheral tissues. Metastases to unilateral, bilateral, or contralateral cervical (levels I, II, III, IV, or V) or retropharyngeal or superior mediastinal lymph nodes (level VII). Figure 4) , PTC (Figure 2) , and PDTC (Figure 3 ; see Table  1 for diagnosis details). Primary thyrocytes derived from nodular tissues were established and grown as described above for normal thyrocytes. Thyroglobulin staining was performed in all cell types after 7 d in culture, and was positive in 77.3% of cells for benign nodule derived thy- Figure 2) . Therefore, our analyses report circadian properties of 71.9% to 93% of human primary thyrocytes with the residual amount of contaminant cells, mostly fibroblasts.
Human primary thyrocytes established from benign nodules exhibited circadian oscillations with similar characteristics to those of normal thyrocytes (Figure 2 , compare blue and black lines). CosinorJ analysis (performed in all cases as depicted in Supplementary Figure 3) revealed that similarly to normal primary thyrocytes, primary cells established from benign nodules exhibited oscillation period of 27.99 Ϯ 1.93 h. Bmal1, Per1-3 and Reverb␣ transcripts exhibited pronounced circadian oscillatory patterns with mesor, amplitude and acrophase close to those of normal thyrocytes (Table 2) , while Cry1-2 and Dbp profiles did not fit CosinorJ criteria for circadian pattern.
Analysis of endogenous clock transcripts in primary thyrocytes established from FTC revealed no significant differences for all of the analyzed clock transcripts when compared to the thyrocytes derived from benign nodules (Supplementary Figure 4 ), or to normal thyrocytes (not shown). Period length, amplitude and acrophase were similar between FTC and thyrocytes established from benign nodules for all of the transcripts, with Bmal1, Per1-3 and Reverb␣ showing pronounced circadian oscillations. Oscillatory profiles of Bmal1, Cry1, Cry2, Per1, and Per3 transcripts assessed in synchronized PTC derived thyrocytes were similar to those of benign nodular and normal thyrocytes (Figure 2) . CosinorJ analysis revealed however reduced circadian amplitude for Per2 in PTC, and no fit to the circadian pattern for this transcript (Table 2) . Thus, clock transcripts in PTC thyrocytes keep their oscillatory properties, except for Per2 exhibiting altered circadian profile ( Figure 2 , Table  2 ). Remarkably, analysis of the primary thyrocytes established from a single case of PDTC revealed altered oscillatory profiles for all of the analyzed transcripts (Figure 3) . Namely, Per1 transcripts exhibited ablated circadian amplitude, while Bmal1, Per2-3, and Reverba transcripts were strongly phase-shifted in comparison to the thyrocytes derived from benign nodules (marked differences in acrophase values, see Table 2 ). Furthermore, an additional single case analysis of primary thyrocytes established from a mixed PDTC-PTC showed flatter amplitude and phase-shifts for all of the transcripts ( Figure 3 , Table  2 ). Taken together these experiments reveal that while thyrocytes from benign nodules perfectly keep their circadian properties, alterations in the clock gene profiles are observed in in vitro synchronized thyrocytes established from PTC and PDTC.
The rhythm alterations we observed in PTC and PDTC derived thyrocytes might be attributed to the circadian phase alteration solely, or to the changes in the circadian period length. To assess the human thyrocyte circadian properties beyond the first cycle kinetics, we turned to more sensitive methodology based on long-term continuous circadian bioluminescence oscillation recording with high temporal resolution. Indeed, human fibroblasts and human islet cells expressing firefly luciferase from circadian promoters were previously shown to exhibit robust circadian bioluminescence rhythms following in vitro synchronization (17, 23) . We thus monitored circadian bioluminescence of human primary thyrocytes transduced with Bmal1-luciferase lentivectors, synchronized by dexamethasone pulse. Oscillation patterns were assessed in healthy, nodular benign and PDTC-PTC derived thyrocytes (Figure 4 ). High-amplitude circadian bioluminescence cycles with the period length of 27.45 Ϯ 0.81 h and 27.90 Ϯ 0.76 h (N ϭ 3 subjects, labeled with * in Table 1) were detected in primary thyrocytes derived from normal tissues and benign nodules for at least three consecutive days, in a good agreement with the endogenous transcript analysis. Of note, PDTC-PTC thyrocytes exhibited remarkably shifted or even antiphasic profiles of Bmal1-luc reporter oscillatory expression over the first cycle only, while getting in phase with healthy and benign nodular counterparts over the following second and third circadian cycles. This experimental approach outcome provides a clear-cut confirmation of the presence of functional circadian oscillators in human primary thyrocytes originated from healthy and benign nodular tissues. Moreover, it suggests that the phase shifts observed in PDTC-PTC derived cells as compared to the benign counterparts are attributed to the first cycle kinetics change and do not imply the circadian period length alterations.
Discussion
Molecular makeup of human thyroid clock
Our study provides for the first time an evidence for cell-autonomous high-amplitude circadian oscillators functional in cultured human primary thyrocytes established from healthy thyroid tissue. Thyrocyte oscillations were assessed by two approaches. Continuous recording of circadian bioluminescence produced by a stably integrated Bmal1-luciferase reporter gene represents a powerful and rather unique tool for circadian oscillator studies in living human primary explants or cells for several consecutive days with high temporal resolution. Dexamethasone synchronized human thyrocytes transduced with Bmal1-luciferase lentivectors exhibited pronounced circadian oscillations for at least 90 h following synchronization ( Figure 4 ). In line with the outcome of reporter experiments, endogenous clock gene expression measurements by qPCR suggested that the core-clock transcripts exhibit circadian oscillatory patterns in synchronized thyrocytes ( Figure 2 ). Both approaches suggested circadian period of about 27 h for this type of cells. Previously circadian timekeepers were characterized in human primary skin fibroblasts and in human pancreatic islets synchronized in culture (17, 23) . In terms of the phase of coreclock transcripts our work is in a good agreement with previous studies. Human thyrocytes exhibit longer oscillation period if compared to skin fibroblasts (24.5 h) or human pancreatic islets (23.6 h; (17, 23) ). Of note, circadian oscillation period length varies significantly among different mouse organ explants cultured in vitro (24), reflecting probably the differences in the general transcriptional rates and cell size among these organs, if comparing liver and lung for example (16, 25) .
Thyrocyte oscillator properties change upon thyroid nodule malignant transformation
Central question addressed in this study was whether circadian clockwork is altered upon thyroid malignancies. We found that transition of normal thyroid tissue to the benign nodule does not alter circadian oscillator function. This held true for both circadian bioluminescence analysis of the cells expressing circadian reporter, and for the endogenous transcript analysis (Figures 4 and 2) . However around-theclock analysis of cells established from PTC and PDTC suggested that malignant transformation of human primary thyrocytes might change their circadian oscillator properties (Figures 2-4, Table 2 ). While in general the oscillators are functional in FTC and PTC derived thyrocytes, Per2 transcript oscillatory profile was altered in PTC (Supplementary Figure 4, Figure 2 , Table 2 ). This tendency becomes more obvious when looking at Per1-3 transcript profiles in PDTC samples ( Figure 3 , Table 2 ), where the amplitude is flattened with complete loss of the oscillatory pattern in Per1. Most importantly we observed dramatic changes in all circadian transcript phase in PDTC, with some of the transcripts being antiphasic to benign counterparts ( Figure 3 , Table 2 ). Observing circadian profile in PDTC-PTC derived thyrocytes over several consecutive days with high temporal resolution (Figure 4) , we conclude that these changes are limited to the phase shift of the first circadian peak, in an agreement with our qPCR measurements (Figure 3 ), while later on PDTC cell profile aligns with healthy and benign counterparts (Figure 4 ). This change attributed to the kinetics of the first circadian cycle might suggest the alteration of clock immediate resetting response in PDTC derived cells. To get further insights to the nature of these alterations, single cell analysis by bioluminescence timelapse microscopy of benign versus PDTC thyrocytes will be required. It is not excluded that glucocorticoid hormones, commonly used by us and others for in vitro cell synchronization and playing an important role for peripheral clock synchronization in vivo (6, 26) , might also play a role in thyroid clock regulation in vivo. Another plausible candidate for the thyroid clock synchronization stimulus would be TSH, exhibiting strongly oscillating profile in the blood (14, 27 ). Of note, the level of TSH receptor in thyrocytes was found to be decreased in PTC (28) . It will be interesting to address in the future if indeed TSH might play a role in thyroid cell synchronization, and whether down-regulation of TSH receptor in PTC might impact on oscillator synchronization properties in these cells.
Two major factors limit the interpretation of our experiments: the low number of available fresh postoperative material of the malignant nodules, and the low number of the primary cells we could establish from each biopsy. Therefore, although the reproducibility among the "around-the-clock" experiments was high, these experiments must be taken with caution due to low number of the analyzed cell lines. The number of cells derived per biopsy allowed performing around-the-clock analysis with 6 h resolution over 36 h, 7 circadian time points in total. To make these dataset's analysis more robust, we developed an adaption of the existing software packages already available for this type of datasets analysis (29 -31) . Our new software, CosinorJ, represents an efficient, fast, user-friendly tool for oscillating dataset analysis, freely available for the research community.
Bmal1 and Cry2: potential candidates for FTC and PTC preoperative diagnostic markers Importantly, our study reveals strong alterations of core-clock transcripts Bmal1 and Cry2 in FTC and PTC, when compared to benign nodules and healthy tissue samples taken at a similar time window of the day (Figure 1) . We demonstrate for the first time that core-clock gene expression levels are altered in thyroid malignancies, namely the up-regulation of Bmal1 and down-regulation of Cry2 in FTC and PTC. Moreover, Bmal1 transcript levels were positively correlated with those of Timp1, also up-regulated in the same PTC samples (Supplementary Figure 1A ; (20) ). This correlation further underscores a potential link between Bmal1 expression level and possibly function, and thyroid nodule tumor progression. Of note, we observe more pronounced differences for coreclock transcript levels in biopsy tissue analysis when compared to our experiments done in in vitro synchronized PTC derived thyrocytes. This discrepancy might be associated with the drastic changes in the cellular environment in in vitro culture situation, associated with the absence of neural and hormonal regulation, disruption of three dimensional tissue structure and alterations in cell-cell communication, changes in epigenetic regulation, and influence of additional factors. Those limitations must be taken into account when drawing conclusions from clock in vitro studies in synchronized cultured cells, although this approach stays rather unique when applied to human circadian clock studies.
There is accumulating evidence on the important role of core-clock components for cell cycle progression and timing of cell division. The circadian oscillator gates cytokinesis to defined time windows in in vitro cultured fibroblasts (7), and regulates key components of the cell cycle wee1, cyclinB1 and cdc2 in mouse liver cells in vivo (9) . Of note, Per2 plays a key role as a tumor suppressor by regulating DNA damage responsive pathways (10) . Moreover, altered expression levels of several clock genes have been described in various types of malignancies: Per1-3 were down-regulated in breast cancer (32); Per1-2, Clock and Cry1 were decreased in skin melanoma (33) ; most of the core-clock transcripts were down-regulated in head and neck squamous cell carcinoma (34) , in pancreatic ductal adenocarcinoma (35) , and in chronic myeloid leukemia (36) . In line with these studies, our experiments demonstrate down-regulation Cry2 levels upon thyroid malignancies. Bmal1 levels were strongly up-regulated in PTC and moderately up-regulated in FTC, suggesting that upregulation of this core-clock transcript might be associated with the pathological conditions as well as its down-regulation, demonstrated in human studies cited above for its association with malignancies, or in Bmal1 knockout study revealing an association with reduced life span and premature aging in mice (37) . Taken together these findings further underscore the link between circadian oscillatory function and cellular malignant transformation. Given that preoperative diagnostics of malignant thyroid nodules is still far from providing reliable responses in numerous cases of suspicious or indeterminate nodules (5, 38) , it would be important to launch a prospective study for Bmal1 and Cry2 transcripts in thyroid nodules to explore the potential employment of these transcript changes for improving FTC and PTC preoperative diagnostics.
In conclusion, we present the first detailed characterization of the human thyroid circadian clockwork and its changes upon malignant transformation. These new insights into the core-clock changes upon thyroid malignancies should contribute to the unresolved issue of the malignant nodule preoperative diagnosis. Exploring human thyroid clock function and its potential role in thyroid nodule malignant transformation represents an important step forward in our understanding of the molecular link between clock function, thyroid tissue physiology and pathophysiology of malignant thyroid nodules.
